Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
SEMA3B Biologics Sequence Review Report 2026: Semaphorin-3B Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of SEMA3B protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
SEMA3A Biologics Sequence Review Report 2026: Semaphorin-3A Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of SEMA3A protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
SCARF2 Biologics Sequence Review Report 2026: Scavenger receptor class F member 2 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of SCARF2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
MMP17 Biologics Sequence Review Report 2026: Matrix metalloproteinase-17 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of MMP17 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
MMP24 Biologics Sequence Review Report 2026: Matrix metalloproteinase-24 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of MMP24 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
MMP9 Biologics Sequence Review Report 2026: Matrix metalloproteinase-9 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of MMP9 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
MMP16 Biologics Sequence Review Report 2026: Matrix metalloproteinase-16 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of MMP16 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
LRP3 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of LRP3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
LRRC32 Biologics Sequence Review Report 2026: Transforming growth factor beta activator LRRC32 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of LRRC32 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
MMP15 Biologics Sequence Review Report 2026: Matrix metalloproteinase-15 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of MMP15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
LRP12 Biologics Sequence Review Report 2026: Low-density lipoprotein receptor-related protein 12 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of LRP12 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
GPR156 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 156 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR156 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
2
3
4
5
6
>>
1503
>